Etiology of and risk factors for transient and persistent aminotransferase elevation in a population of virus-free blood donors: A multicentre study

Digestive and Liver Disease

Volumn 42, Issue 6, 2010, Pages 441-445

  Morisco, Filomena ^a   Stroffolini, Tommaso ^b   Mele, Alfonso ^c   Taliani, Gloria ^b   Smedile, Antonina ^d   Caronna, Stefania ^d   Tosti, Maria E ^c   Niro, Grazia ^e   Levrero, Massimo ^f   Fiorillo, Maria T ^g   Amoruso, Daniela C ^a   Ascione, Antonio ^h   Caporaso, Nicola ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

^c Surveillance and Health Promotion   (Italy)

^d Division of Gastroenterology and Hepatology   (Italy)

^e CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g Calabrese Association of Hepatology   (Italy)

^h Division of Hepatology   (Italy)

Author keywords

Aminotransferase; Blood donors; Chronic hepatitis; Non alcoholic steatohepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; PAINT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD DONOR; BODY MASS; CONTROLLED STUDY; DRUG USE; FEMALE; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; MALE; PRIORITY JOURNAL; RISK FACTOR; BLOOD; BLOOD TRANSFUSION; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE TRANSMISSION; ENZYMOLOGY; FOLLOW UP; GENETICS; HEPACIVIRUS; HEPATITIS B; HEPATITIS C; IMMUNOLOGY; MULTICENTER STUDY; PREVENTION AND CONTROL; PROCEDURES; RETROSPECTIVE STUDY; TRANSMISSION; VIROLOGY;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BLOOD DONORS; BLOOD TRANSFUSION; BODY MASS INDEX; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL;

EID: 77952743500     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2009.06.017     Document Type: Article

References (24)

1. Pendino G.M., Mariano A., Surace P., Caserta C.A., Fiorillo M.T., Amante A., et al. Prevalence and etiology of altered liver tests: a population-based survey in a Mediterranean town. Hepatology 2005, 41:1151-1159.
2. Bellentani S., Tiribelli C., Saccoccio G., Sodde M., Fratti N., De Martin C., et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology 1994, 20(6):1442-1449.
3. Clark J.M., Brancati F.L., Diehl A.M. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003, 98:960-967.
4. Ioannou G.N., Boyko E.J., Lee S.P. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol 2006, 101:76-82.
5. Daniel S., Ben-Menachem T., Vasudevan G., Ma C.K., Blumenkehl M. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients. Am J Gastroenterol 1999, 94:3010.
6. Katkov W.N., Friedman L.S., Cody H., Evans A., Kuo G., Choo Q.L., et al. Elevated serum alanine aminotransferase levels in blood donors: the contribution of hepatitis C virus. Ann Intern Med 1991, 115:882-884.
7. Sherwood P., Lyburn I., Brown S., Ryder S. How are abnormal results for liver function tests dealt with in primary care? Audit of yield and impact?. Br Med J 2001, 322:276-278.
8. Ruhl C.E., Everhart J.E. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2003, 124:71-79.
9. Morisco F., Rosmini F. Reliability of measurements of serum alanine transaminase activity and the impact on the cut-off value for the selection of blood donors. Haematologica 2002, 87:559-560. the ALT Study Group.
10. Ishak K., Baptista A., Bianchi L., Callea F., De Groote J., Gudat F., et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995, 22(6):696-699.
11. Brunt E.M., Janney C.G., Di Risceglie A.M., Neuschwander-Tetri B.A., Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999, 94:2467-2474.
12. Hosmer D.W., Hosmer T., Le Cessie S., Lemeshow S. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med 1997, 16(9):965-980.
13. Stata Corp. Stata statistical software: release 8.0 2003, Stata Corporation, College Station, TX.
14. Sagnelli E., Stroffolini T., Mele A., Almasio P., Coppola N., Ferrigno L., et al. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases. J Med Virol 2005, 75(4):522-527.
15. Morisco F., Pagliaro L., Caporaso N., Bianco E., Sagliocca L., Fargion S., et al. Consensus recommendations for managing asymptomatic persistent non-virus non-alcohol related elevation of aminotransferase levels: suggestions for diagnostic procedures and monitoring. Dig Liver Dis 2008, [Epub ahead of print].
16. Sgro C., Clinard F., Ouazir K., Chanay H., Allard C., Guilleminet C., et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 2002, 36:451-455.
17. Andrade R.J., Lucena M.I., Fernandez M.C., Pelaez G., Pachkoria K., García-Ruiz E., et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005, 129:512.
18. Meier Y., Cavallaio M., Roos M., Pauli-Magnus C., Folkers G., Meier P.J., et al. Incidence of drug-induced liver injury in medical inpatients. Eur J Clin Pharmacol 2005, 61:135-143.
19. Bellentani S., Saccoccio G., Costa G., Tiribelli C., Manenti F., Sodde M., et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 1997, 41(6):845-850.
20. Becker U., Deis A., Sørensen T.I., Grønbaek M., Borch-Johnsen K., Müller C.F., Schnohr P., Jensen G. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996, 23(5):1025-1029.
21. Patt C.H., Yoo H.Y., Dibadj K., Flynn J., Thuluvath P.J. Prevalence of transaminase abnormalities in asymptomatic, healthy subjects participating in an executive health-screening program. Dig Dis Sci 2003, 48:797-801.
22. Berasain C., Betés M., Panizo A., Ruiz J., Herrero J.I., Civeira M.P., et al. Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut 2000, 47:429-435.
23. Morisco F., Di Lonardo A., Stroffolini T., Leone D., Caporaso N. High prevalence of non-virus/non-alcohol-related alanine-aminotransferase increase in blood donors. Haematologica 2001, 86:1116.
24. Skelly M.M., James P.D., Ryder S.D. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. J Hepatol 2001, 35(2):195-199.